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Abstract
 .Several mechanisms have been postulated for the formation of advanced glycation endproducts AGEs from glycated
 .proteins; they all feature protein-bound carbonyl intermediates. Using 2,4-dinitrophenylhydrazine DNPH , we have
detected these intermediates on bovine serum albumin, lysozyme and b-lactoglobulin after in vitro glycation by glucose or
fructose. Carbonyls were formed in parallel with AGE-fluorophores, via oxidative Maillard reactions. Neither Amadori nor
Heyns products contributed to the DNPH reaction. Fluorophore and carbonyl yields were much enhanced in lipid-associated
proteins, but both groups could also be detected in lipid-free proteins. When pre-glycated proteins were incubated in the
absence of free sugar, carbonyl groups were rapidly lost in a first-order reaction, while fluorescence continued to develop
beyond the 21 days of incubation. Another unexpected finding was that not all carbonyl groups were blocked by
aminoguanidine, although there was complete inhibition of reactions leading to AGE-fluorescence. It is suggested that
carbonyls acting as fluorophore precursors react readily with aminoguanidine, while others are resistant to this hydrazine,
possibly because they are involved in ring closure. Factors influencing the relative rates of acyclisation and hydrazone
formation are discussed, together with possible implications for antiglycation therapy.
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1. Introduction
The reactions of reducing sugars such as glucose
with protein amino groups are thought to contribute
to secondary complications in diabetes and similar
symptoms in ageing. They lead to the build-up of
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acetic acid
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browning products, fluorophores, crosslinks and other
compounds known collectively as advanced glycation
 .endproducts AGEs or Maillard products. In vitro,
these reactions are greatly reduced by aminoguani-
 .dine AG , a hydrazine that is currently under clinical
trial for the relief of diabetic complications. Mecha-
nistically, AG would be expected to block AGE
formation by reacting with carbonyl intermediates,
and indeed the expected triazine products have been
w xisolated 1 from the in vitro reaction of aminoguani-
dine with deoxyglucosone; this dicarbonyl sugar is
w xreleased from protein Amadori products 2 and in-
w xvolved in protein crosslinking 3 . However,
protein-bound carbonyl intermediates have long been
postulated in the proposed routes to AGEs such as
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w x w xcarboxymethyllysine 4 , pentosidine 5 and pyrra-
w xline-derived crosslinks 6 . Carbinolamines are among
other protein-bound carbonyl intermediates in the
w xrecently proposed Namiki route to AGEs 7 . In this
paper we investigate the role in AGE formation of
these other potential targets for AG.
Recently it has become clear that the route to
AGEs may not always involve simple glycation, i.e.
the formation of Schiff base, its conversion to
 .Amadori product AP and subsequent oxidation to
AGEs. The Schiff base may be oxidised directly,
w xbypassing the AP 7 , or protein amino groups may
be attacked by sugar oxidation products such as
w xglyoxal 8 . We are interested in the role of protein-
bound carbonyls in any of these routes, which are
referred to here simply as Maillard reactions.
 .We have used 2,4-dinitrophenylhydrazine DNPH
to investigate the role of protein-bound carbonyls in
the formation of fluorescent AGEs from glycated
 .bovine serum albumin BSA , b-lactoglobulin and
lysozyme. Here we present evidence that such inter-
mediates are formed only in the presence of sugar,
and that under physiological conditions they may act
as precursors to the fluorescent AGEs produced in
later stages of the Maillard reaction.
The early fructose-protein equivalent of the
Amadori product is the Heyns product, which is
grossly underestimated by colorimetric assays used
w xfor AP 9 . However, we have previously reported
w x w x10 an adaptation of the Levine method 11 , in
which post-Heyns compounds react strongly with
DNPH. This method allowed us to investigate the
mechanisms of AGE formation from both glucated
and fructated proteins. We attach particular emphasis
to fructose, as a potent glycating agent whose serum
concentrations can rise to 0.5 mM in healthy individ-
w x w xuals 12 and 2 mM in cirrhosis 13 ; intracellular
fructose levels in tissues susceptible to diabetic com-
plications are also elevated by the polyol pathway in
w xdiabetes 14 .
2. Materials and methods
2.1. Chemicals
These were obtained from BDH or Sigma. Bovine
serum albumin was Sigma fraction V, 96–99% pure;
lysozyme was from chicken eggwhite and b-lacto-
globulin from bovine milk.
2.2. In ˝itro glycation
This was carried out at 378C and pH 7.4, using 0.1
M sodium phosphate buffer containing 3 mM Na
azide. Proteins BSA at 40 mgrml; lysozyme and
.b-lactoglobulin at 10 mgrml were incubated in
 .  .glucose 0.2 M or fructose 0.05–0.5 M, as stated
for up to 21 days, and then stored frozen at y208C.
2.3. Dialysis
To remove free sugar before periodate and protein
assays, and before re-incubation under sugar-free
conditions, glycated proteins were subjected to ex-
haustive dialysis against phosphate buffer. This was
carried out at 48C in a Bethesda Research Lab micro-
dialysis apparatus, with eight, equally spaced buffer
changes over 4 days. Buffer volume was 100-fold
greater than sample volume.
2.4. Re-incubation in the absence of free sugar
BSA that had been previously glycated in 0.05 M
fructose was dialysed free of unbound sugar, and
placed back in the 378C incubator for up to 15 days.
2.5. Periodate assay for AP and other periodate-posi-
ti˝e material
This was an adaptation of our standard microassay
w x15 , using 30 and 60 ml of all solutions where 20
and 40 ml were previously used, respectively.
2.6. DNPH assay for protein-bound carbonyl groups
w xThe method of Levine et al. 11 was adapted, as
w xreported briefly in 10 .
Duplicate 100-ml aliquots containing approx. 1
.mg of protein were mixed with 400 ml of 7 mM
DNPH in 2 M HCl; a third 100-ml aliquot was mixed
with 2 M HCl, to allow calculation of any interfer-
ence from yellow chromophores in glycated protein.
After 1 h at room temperature for formation of
DNP-hydrazones, protein was precipitated by adding
 .500 ml of trichloroacetic acid 4%, wrv . The pellet
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collected by centrifuging for 5 min at 14,000=g
 .was re-dispersed in ethanolrethyl acetate 1:1, vrv ,
in order to remove unreacted DNPH. After 4 such
washes, the pellet was re-suspended in 0.6 ml of a 6
M guanidine hydrochloride solution in 20 mM phos-
phate buffer, already adjusted to pH 2.3 with
trifluoroacetic acid. The protein was fully re-dis-
solved only by freezing overnight at y208C and
thawing.
Absorbance at 379 nm was read by pipetting 200-
ml aliquots of re-dissolved protein into a microplate
colorimeter Bio-tek microplate autoreader EL311,
.Luminar Technology from Anachem .
Carbonyl concentration was calculated from the
net absorbance using a molar absorbance of 22,000
y1 y1 w xM cm 11 .
2.7. Assay of AGE-fluorophores
Fluorescence of glycated proteins diluted to con-
.centrations below 1 mgrml was read at ex 325
nmrem 375 nm, the wavelengths optimum for AGE
biomarker pentosidine. The Perkin-Elmer lumines-
cence spectrometer LS50B was calibrated daily
against quinine sulphate, 1 ngrml in H SO .2 4
2.8. Protein concentration
This was determined by the bicinchoninic acid
w xmethod of Smith et al. 16 , using the BCA assay kit
 .from Pierce Chester, U.K. .
3. Results
Glycated proteins were analysed for carbonyl con-
tent by reaction with DNPH, and for fluorescence at
the wavelengths optimum for pentosidine. Fig. 1
shows that carbonyl and fluorescent groups were
produced on glycated BSA, from both glucose and
fructose. Yields were considerably higher with fruc-
tose than glucose, and were greatly enhanced by the
presence of lipid. Glycation of delipidated BSA gave
comparatively little fluorescence or carbonyl even
with fructose, and Table 1 suggests that in general,
carbonyl groups are more readily detected on lipid-
associated proteins. Preliminary work on native BSA
delipidated after glycation using activated charcoal
 .  .Fig. 1. Glycation of BSA 40 mgrml by 0.05 M fructose F
 .and 0.2 M glucose G as monitored by formation of protein-
 .  .bound carbonyl groups A and fluorophores B . Carbonyls and
fluorophores were formed from both sugars, with fructation
considerably faster than glucation. Controls were incubated un-
.der identical conditions, without sugar.
w x17 , showed that after 10 days in 0.5 M fructose, the
 .majority 60% of carbonyls separated into the lipid
fraction. However, after 21 days glycation the overall
carbonyl content had increased, with 70% now in the
protein fraction.
The metal chelator DETAPAC was a potent in-
hibitor, greatly reducing yields of both carbonyl and
fluorescent groups, as shown for fructated BSA in
Fig. 2A and B. Similar results were obtained with
glucose. Hence both groups appear to be the product
of metal-catalysed glycoxidation reactions, which are
enhanced by lipid and catalysed here by traces of
transition metal in phosphate buffer.
When BSA samples previously fructated to differ-
ent extents, were re-incubated at 378C in sugar-free
phosphate buffer, there was a steady increase in
fluorescence and a sharp drop in carbonyl content
 .Fig. 3 . This was particularly clear with the most
heavily fructated samples bottom line of Fig. 3A and
.top line of Fig. 3B . McPherson et al. found a similar
increase in the fluorescence and crosslinking of pre-
w xfructated ribonuclease 18 . With BSA, Fig. 3 shows
that the carbonyl groups were lost transformed to
.other products in a first-order reaction that appeared
to be independent of initial carbonyl concentration.
Whatever the extent of previous fructation, all sam-
ples had a half-life around 4 days under these condi-
tions. In contrast, the rate of fluorophore develop-
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 .Fig. 2. Effects of metal chelator DETAPAC 1 mM on formation
 .  .of protein-bound carbonyl groups A and fluorophores B dur-
ing glycation of BSA by 0.5 M fructose. Protein was incubated in
 .  .fructose squares , fructose with DETAPAC triangles , or buffer
 .alone circles . There was around 80% inhibition of both pro-
cesses.
ment never flattened off. So although carbonyl groups
are clearly formed before fluorophores in the se-
quence of Maillard intermediates, they may be pre-
cursors of both fluorescent and nonfluorescent AGEs.
Table 1
Effect of lipid on output of protein-bound carbonyl and fluores-
cent AGEs
Moles of carbonylr Fluorescencer
mole of protein mole of protein
Native BSA 0.35 366
Delipidated BSA 0.06 15
b-Lactoglobulin 0.31 310
Lysozyme 0.06 35
Figures are for 7 days incubation in 0.1 M fructose. Fluorescence
is in arbitrary units.
How far can these DNPH-reactive carbonyl com-
pounds be identified with known Maillard intermedi-
ates? Small molecules like 3-deoxyglucosone and
glyoxal can be discounted, since they would be re-
moved in the supernatant after precipitation of the
protein DNPH-hydrazone with TCA. Acyclic forms
of AP and Heyns product might be expected to react
with DNPH but surprisingly, our data suggest they
contributed little to the reaction here. Firstly, the
build-up of AP, as monitored by the periodate assay,
 .  .Fig. 3. Loss of carbonyl groups A and gain of fluorophores B during re-incubation of fructated BSA at 378C in the absence of free
 .  .sugar. The BSA was previously fructated in 0.05 M fructose at 378C for periods of 7 days triangles , 14 days stars and 21 days
 .diamonds . Unbound sugar was removed at 48C by dialysis against phosphate buffer for 4 days; during this time there was considerable
loss of carbonyl groups, and a small gain in fluorescence. Samples were then immediately re-incubated at 378C in sugar-free buffer,
 .starting at ‘0 days’ as indicated on the x-axis. In the controls circles fructose was omitted from the first incubation.
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Fig. 4. Yield of periodate-positive material on glycation of native
 .  .BSA full lines and delipidated BSA dotted lines by glucose
 .  .0.2 M and fructose 0.05 M . Protein was incubated in glucose
 .  .  .triangles , fructose squares , or buffer alone circles . Delipida-
tion had little effect on formation of AP from glucose, but
considerably reduced the formation of periodate-positive material
from fructose.
 .was unaffected by lipid Fig. 4 , and both native and
delipidated BSA gave similar yields of periodate
 .positive material PPM . Secondly, AP yields were
enhanced rather than depleted by adding DETAPAC
Fig. 5. Effect of 1 mM DETAPAC and 50 mM aminoguanidine
 .AG on yield of Amadori product from BSA glucated in 0.2 M
 .glucose. Protein was incubated in glucose alone triangles , glu-
 .cose with aminoguanidine diamonds , or glucose with DETA-
 .  .PAC stars . The control no symbols was in buffer alone.
Yields rose some 60–600% with DETAPAC and some 33–250%
with aminoguanidine. Greatest increases were seen after rela-
tively short glycation periods.
 .Fig. 5 . These results are in sharp contrast to the
effects of lipid and DETAPAC on carbonyl content
 .as measured by DNPH Table 1 and Fig. 2A , strongly
suggesting that this reagent does not react with the
Amadori carbonyl group.
It is more difficult to see whether acyclic Heyns
product is contributing to the reaction with DNPH,
since the periodate assay measures only formal-
dehyde liberated from cis diol groups or from
eneaminol groups in the same configuration; neither
of these configurations appear in the major Heyns
w xproduct 9,19 . Fig. 4 shows that lipid significantly
enhanced the yield of PPM in fructated BSA, but not
in glucated BSA. This suggests that different factors
affect the formation of PPM from the two different
sugars. Hence the small amount of PPM formed by
fructation is not the fructose equivalent of Amadori
product, but more likely some post-Heyns intermedi-
ate or autoxidation product with the necessary perio-
date-reactive grouping.
Any post-Amadori or post-Heyns carbonyl com-
pound susceptible to DNPH would be expected to
react with aminoguanidine, another hydrazine that
has received much attention for its therapeutic poten-
tial. Fig. 6 shows that during the first 4 days of
Fig. 6. Effect of aminoguanidine on formation of protein-bound
 .  .carbonyl groups A and fluorophores B during glycation of
BSA by 0.2 M glucose. Protein was incubated in glucose trian-
.  .gles , glucose with aminoguanidine diamonds , or buffer alone
 .circles . The reduction in carbonyl output was particularly
marked in the early stages of glycation; fluorescence output was
fully inhibited throughout.
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incubation, 50 mM aminoguanidine almost com-
pletely suppressed the formation of both carbonyl and
fluorescent groups from glucose. Fructose gave simi-
lar results. After 11 days, fluorescence output was
fully inhibited, while carbonyl output was some 50%
that of the uninhibited sample. Again this is in sharp
contrast to AP output, which increased in the pres-
 .ence of aminoguanidine Fig. 5 . Even with only 4
mM aminoguanidine, fluorescence output was still
completely inhibited, while carbonyl output was re-
 .duced by only 30% results not shown .
4. Discussion
Reaction with DNPH is a standard method for
detecting carbonyl groups, and can be used to follow
w xchanges on protein oxidation 11 . However, the car-
bonyls detected under our conditions are clearly the
result of glycoxidation or sugar autoxidation, since
there is little DNPH-reactivity from proteins incu-
bated in buffer alone. Some carbonyls may be purely
amino acid in origin, like the semialdehydes pro-
duced by metal-catalysed oxidation of lysine, argi-
 w x.nine and proline see table 1 in Ref. 20 ; for these to
contribute to the DNPH reaction here, their formation
must somehow be enhanced by the presence of sugar.
The other carbonyls detected by DNPH will be true
Maillard products, incorporating atoms from both
sugar and amino moieties. The question then arises as
to which of these products we are seeing here.
Small-molecule carbonyl compounds like free glyox-
als or glucosones can be discounted, since we are
dealing only with molecules precipitated by TCA.
The protein-bound carbonyls that we detect could be
 .part of the Amadori or Heyns product, or of a lipid
glycoxidation product. For the following reasons, we
believe neither of these alternatives gives the whole
picture.
Although both Amadori and Heyns products have
prominent carbonyl groups, these do not appear to
contribute to DNPH-reactivity here. The carbonyls
we see are decreased by delipidation and by adding
DETAPAC or aminoguanidine Table 1; Figs. 2 and
.6 , whereas our yields of AP are unaffected by
delipidation and enhanced by DETAPAC and
 .aminoguanidine Figs. 4 and 5 . The periodate assay
for glucated protein is generally assumed to measure
w xAP 21 , and gives results comparable to the thio-
barbituric acid and other assays, in terms of moles
w xAP per mole of protein 9 . Therefore this evidence
strongly suggests that DNPH is reacting with some-
thing other than the AP. It also suggests that cyclic
and acyclic forms of AP are not in rapid equilibrium.
This apparent anomaly gains support from the work
w xof Fischer and Winterhalter 22 who found little
reaction between glycated haemoglobin and phenyl-
hydrazine, and concluded that the proportion of
acyclic AP is too low for easy chemical assay. This
w xled Schleicher and Wieland in their review 23 to
reject phenylhydrazine as a reagent for assaying gly-
cated protein. In contrast, DNPH readily forms hy-
drazones with the AP of glyceraldehyde and
haemoglobin, since here the sugar is too short to
w xcyclise 24 .
If neither Amadori or Heyns products react with
DNPH, what about the lipids? Quantitative data are
needed to assess the possible contribution of lipid
carbonyls to the DNPH reaction. However, as tran-
sient intermediates rather than endproducts, AGE car-
bonyls are hard to quantify. See, for example, the
w x .controversy over pyralline levels in vivo 25 . Fur-
thermore, the molar absorbance of DNP-hydrazones
depends greatly on the structure of adjacent residues
w x26 and will therefore vary between proteins. The
figures for moles of carbonyl per mole of protein in
Table 1 must therefore be treated as approximate.
Nonetheless it is clear from comparing native and
delipidated BSA, that lipid can greatly enhance the
output of carbonyl groups. Similarly, the lipid-free
lysozyme gives fewer carbonyls than b-lacto-
globulin, another small protein with one mole of lipid
w xper mole 27 . The protein-bound carbonyls produced
in these lipid-enhanced reactions could derive solely
from amino acid residues, or from lipids or from a
mixture of both. Bucala et al. found antibody-reactive
AGEs on both lipid and apoprotein fractions of in
vivo glycated lipoprotein; lipid AGEs in particular
w xwere enhanced in diabetes 28 . Whatever their ori-
gin, our lipid-enhanced carbonyls are clearly the re-
sult of glycoxidation or sugar autoxidation. No pro-
tein gave significant readings in the absence of sugar.
Equally, it is clear that lipid is not essential for the
 .formation of AGE carbonyls. Lysozyme Table 1
 w x.and delipidated BSA Table 1 and Ref. 29 con-
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tribute both protein-bound carbonyls and fluoro-
phores, although the yields are considerably lower
than for lipid-associated proteins. This suggests that
AGE formation may be particularly rapid in lipid-as-
sociated proteins and near cell membranes.
Having discounted in lipid-free proteins, the
 .Amadori Heyns products as major contributors to
the DNPH reaction, we are left with some unidenti-
fied Maillard intermediate as the source of these
DNPH-reactive carbonyls. Protein-bound sugar
derivatives, both mono- and di-carbonyl, feature in
most of the reaction schemes proposed for AGE
w xformation, e.g. see 4–7 . It is one or more of these
carbonyls that we appear to be detecting with the
DNPH assay. They could be among the ‘oxidised
intermediates’ that form in the lag phase before im-
mune-reactive AGEs can be detected see fig. 1D in
w x.Ref. 34 .
When fructated BSA was incubated under physio-
logical conditions in the absence of excess sugar, the
carbonyls disappeared in a first-order process Fig.
.3A ; this is consistent with their role as transient
intermediates. Of the many AGEs into which car-
bonyls may be converted, we followed the rise of
 .fluorophores only Fig. 3B . These constitute a very
w xminor fraction of AGEs 30,31 , and arise several
w xdays before crosslinks 32 and also before the anti-
w xbody-reactive AGEs 33 which are now thought to
w xbe mainly carboxymethyllysine derivatives 34 . Some
AGE-fluorophores may be derived directly from the
carbonyl intermediates as suggested for pentosidine
w x5 , but since fluorophore build-up continues long
after carbonyl decay is complete, there must be fur-
ther ‘slow’ reactions on the fluorophore pathway.
There may also be carbonyl-independent routes, al-
though the effect of aminoguanidine argues against
 .this see below .
The role of carbonyl intermediates in AGE forma-
tion was further elucidated by inhibitor studies. In
vitro glycoxidation and sugar oxidation reactions are
often catalysed by traces of transition metal in phos-
w xphate buffer 35 . The inhibitory effect of DETAPAC
 .Fig. 2 suggests that one such oxidation step can be
pinpointed to the production of non-Amadori, pro-
tein-bound carbonyls. This should be a good target
for antioxidant therapy aimed at reducing AGEs.
 .Aminoguanidine boosted the yield of AP Fig. 5
yet surprisingly, it only partially inhibited the forma-
tion of protein-bound carbonyls, except for short
 .glycation periods up to 4 days Fig. 6 . Could this be
an artifact of the DNPH assay? Since DNPH and
glycated protein are left to react at pH 2.3, there is
the possibility that acid hydrolysis degrades any
aminoguanidine-protein complex, releasing free car-
bonyls for immediate reaction with DNPH. However
reducing the pH 2.3 incubation from 60 to 15 min did
not reduce the number of DNPH-reactive carbonyls.
So the puzzle remains, that aminoguanidine fully
inhibited fluorescence output without apparently
blocking all the carbonyl groups. Similarly, Requena
et al. found that low concentrations of aminoguani-
dine inhibited AGE fluorescence without blocking
w x .carbonyl groups on the AP 36 . It has long been
suggested that the major fluorophore pentosidine has
w xa carbonyl precursor 5 , and this presumably is
sensitive to aminoguanidine. However, there could be
other protein-bound carbonyl groups, less reactive
towards hydrazines because they are involved in ring
closure. It is noteworthy that glucose itself reacts
w xvery slowly with aminoguanidine 37 and this would
explain how the hydrazine is effective even when
there is a large molar excess of glucose see, e.g.,
w x.Fig. 6 and Ref. 36 . Aminoguanidine may also be a
rather weak hydrazine. If acyclisation is slower than
hydrazone formation, then acyclisation becomes the
w xrate-determining step; Harding 38 makes a similar
w xpoint. Kaanane and Labuza 39 have pointed out in
the context of glycation, that we know rather little
about acyclisation rates of sugars and their deriva-
tives, except that they would be expected to vary with
pH and ionic composition. Phosphate anions have
been shown to catalyse acyclisation of the small
w xmodel AP, deoxyfructosyl hippuryllysine 40 . So the
microenvironment of protein-bound carbonyls could
also be critical for acyclisation, causing some car-
bonyls to be less reactive than others. We may be
seeing this effect in the poor reactivity of AP towards
DNPH, although here there could also be steric hin-
drance, with the bulky aromatic reagent unable to
reach sugar carbonyls close to the lysine side-chain.
These findings could be significant for the design
of antiglycation drugs. Does the success of
aminoguanidine rest on its ability to discriminate
between carbonyl groups, attacking only those that
cannot be involved in ring closure? It would clearly
be useful to have more information on what influ-
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ences hydrazine reactivity and acyclisation rates in
sugars and their derivatives.
In summary, we have detected protein-bound car-
bonyl groups as ‘early’ Maillard intermediates, on a
number of proteins glycated by glucose or fructose.
Fluorescent compounds, in contrast, are known to be
‘late’ AGEs. Yields of both fluorophore and carbonyl
are enhanced in lipid-associated proteins. Their out-
put is dependent on glycoxidation or sugar autoxida-
tion, and blocked by aminoguanidine. Significantly,
not all protein-bound carbonyls are equally reactive
towards aminoguanidine. The DNPH reaction thus
gives useful insights into the mechanisms of AGE
formation, and its possible control by aminoguani-
dine.
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